CBD's drug exclusion problem makes it uniquely risky as a supplement ingredient. Here's what FDA allows, what it prohibits, and the current enforcement posture.

Where cannabis and CBD brands can advertise in 2026: Google, Meta, and TikTok policies, state marketing rules, FTC substantiation, and owned channels.

FDA blocks CBD in supplements and food, but cosmetics remain workable. MoCRA registration, listing, and the cosmetic-vs-drug claim line explained for 2026.

FDA still has no CBD labeling framework in 2026. States fill the gap: QR codes, COA links, mg disclosures, warnings. What your label needs, state by state.

What a hemp COA must show, why most CBD products fail potency checks, and how to substantiate lab-tested and THC-free claims under FTC rules. A brand guide.

Federal law bans synthetic cannabinoids and caps total THC at 0.4 mg per container on November 12, 2026. What delta-8 sellers must do in the wind-down window.